We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 2,340

Electricity generators and embedded benefits - cause for concern?
  • Gowling WLG
  • United Kingdom
  • September 20 2016

Embedded benefits are savings or payments available to generating stations that are directly connected to distribution networks (commonly referred to


Can post-Brexit UK remain involved in the UP and UPC system?
  • Gowling WLG
  • European Union, United Kingdom
  • September 16 2016

An Opinion, by English barristers Richard Gordon QC and Tom Pascoe, has been published considering the effect of Brexit (i.e. Departure from the EU


Challenger banks: risks and rewards for new entrants
  • Gowling WLG
  • United Kingdom
  • September 14 2016

Challenger banks, which are set up to compete with the larger traditional banks, have seen rapid growth in the wake of increased openness to change


Data breach figures in the health sector are skewed - but only for now
  • Gowling WLG
  • United Kingdom
  • September 13 2016

The Information Commissioner's Office (ICO), regulator of the Data Protection Act 1998 and other privacy related legislation, recently published its


Suspicion of fraud does not prevent unravelling a settlement
  • Gowling WLG
  • United Kingdom
  • September 6 2016

Suspecting that an opponent is lying and not just exaggerating a bit is one thing, proving it is another thing entirely. Insurers (and other


Reforms to the taxation of non-domiciled individuals: updated proposals
  • Gowling WLG
  • United Kingdom
  • September 1 2016

On Friday 19 August 2016, the Government published its long-awaited follow-up consultation on the proposals for reform of the taxation of non-UK


Eli Lilly's erectile dysfunction patent stands up to scrutiny
  • Gowling WLG
  • United Kingdom
  • September 1 2016

The English High Court (Patents Court) has ruled in a patent dispute concerned with the treatment of erectile dysfunction. Actavis and Mylan had


Court of Appeal confirms Genentech Herceptin formulation patents invalid
  • Gowling WLG
  • United Kingdom
  • August 30 2016

The Court of Appeal has confirmed that two Genentech patents concerning lyophilised formulations of trastuzumab (the active ingredient in Herceptin


Brexit - what next for health & safety and your business?
  • Gowling WLG
  • European Union, United Kingdom
  • August 1 2016

The core legislation, around which the UK's health and safety regulations have evolved, is the Health and Safety at Work etc Act 1974 (the HSWA


Brexit: implications for wealthy international individuals and their families
  • Gowling WLG
  • European Union, United Kingdom
  • July 28 2016

On June 23 2016 the United Kingdom voted to leave the European Union by a majority of 51.9 to 48.1 (of the 72.2 turnout of eligible voters). In